A report by Santin et al. [46] demonstrated that serum TGFβ increases by roughly 50% in ovarian cancer patients compared to controls, highlighting the importance of TGFβ in ovarian cancer. The gene discussed is TGFB1; the disease is ovarian carcinoma.